Innovation Trends in MedTech: Structural and Interventional Heart Failure
Cardiovascular Research Foundation
34 videos
The Cardiovascular Research Foundation is a pre-eminent force in the progress against cardiovascular disease and, for nearly 30 years, a proven partner for researchers, physicians, and related...
Read More
The Cardiovascular Research Foundation is a pre-eminent force in the progress against cardiovascular disease and, for nearly 30 years, a proven partner for researchers, physicians, and related health professionals.
Speakers
Works at Cardiovascular Research Foundation, New York, NY, USA. Features in 11 videos on Wondr Medical. Daniel...
Works at Cardiovascular Research Foundation, New York, NY, USA. Features in 11 videos on Wondr Medical. Daniel Burkhoff generally speaks on Acute Heart Failure, PFO/ASD (Closure), Stroke: Persistent Foramen Ovale and PFO closure, 3d Transoesphageal Echo, and Pulmonary Hypertension.
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst...
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).
Dr. Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory in...
Dr. Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory in 2018, she was the director of minimally invasive cardiac surgery and the surgical director of the heart valve program at the University of Louisville. Dr. Grubb is a champion for combating women's heart disease and is dedicated to improving the lives of all patients, both male and female, through innovation and by building collaborative teams to promote a patient-centered approach to the treatment of cardiovascular disease. Dr. Grubb has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy, and the GORE conformable TAG thoracic endoprosthesis for the primary treatment of aneurysms of the descending thoracic aorta. Dr. Grubb received her MD degree from the Keck School of Medicine and her Master of Health Administration from the Sol Price School of Public Policy. She completed her general surgery residency at the University of Illinois at Chicago, her fellowship in cardiothoracic surgery at the University of Virginia in Charlottesville, and her fellowship in interventional cardiology and transcatheter therapies at New York Presbyterian/Columbia University Medical Center.
Dr. Reisman received his Medical Degree from Sackler School of Medicine, New York State Program. He did his...
Dr. Reisman received his Medical Degree from Sackler School of Medicine, New York State Program. He did his Internship at Robert Wood Johnson Hospital in New Brunswick. He finished both Residency in Internal Medicine and Cardiology Fellowship at St. Luke’s Roosevelt Hospital in New York. Dr. Reisman completed Interventional Cardiology at University of California San Diego Medical Center in San Diego. Dr. Reisman has a very productive career as exemplified by authorship and co-authorship of over 100 publications. He is a highly regarded practitioner in the field of interventional cardiology and a leader in national education forum. Dr. Reisman serves as Director of Structural Heart Disease at Weill Cornell Medicine
Works at Hamburg, Germany. Features in 8 videos on Wondr Medical. Martin Bergmann generally speaks on Atrial...
Works at Hamburg, Germany. Features in 8 videos on Wondr Medical. Martin Bergmann generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Acute Heart Failure, and Stroke: LAA and LAA closure.
A postdoctoral research fellow at Vanderbilt University Medical Center, Pittsburgh, Pennsylvania, US. Features in 1...
A postdoctoral research fellow at Vanderbilt University Medical Center, Pittsburgh, Pennsylvania, US. Features in 1 video on Wondr Medical. Rei Ukita generally speaks on Heart Failure, Chronic Heart Failure, and Innovation.
Sanjiv J. Shah, MD is the Neil Stone, MD Professor in the Division of Cardiology, Department of Medicine; Director of...
Sanjiv J. Shah, MD is the Neil Stone, MD Professor in the Division of Cardiology, Department of Medicine; Director of the T1 Center for Cardiovascular Therapeutics; and Director of the Heart Failure with Preserved Ejection Fraction Program at Northwestern University Feinberg School of Medicine. Dr. Shah’s clinical expertise and research focuses on heart failure with preserved ejection fraction (HFpEF), which is one of the most prevalent cardiovascular diseases and for which there are few proven treatments. In 2007, Dr. Shah started the first dedicated HFpEF program in the world at Northwestern University. The Northwestern University HFpEF program has served as a model for several other similar programs in the United States and throughout the world. Dr. Shah has been continuously funded by grants from the American Heart Association and the National Institutes of Health since 2008. He directs a laboratory that investigates the pathogenesis of heart failure; conducts multicenter clinical trials of novel therapeutics for heart failure, pulmonary hypertension, and cardiac amyloidosis; and develops novel techniques for machine learning and artificial intelligence for the classification, diagnosis, and tracking of cardiovascular diseases. His is currently the principal investigator of 3 ongoing R01 grants from the National Institutes of Health and an American Heart Association Strategically Focused Research Network grant. He is also the Northwestern University principal investigator for the National Heart, Lung, and Blood Institute (NHLBI) Heart Failure Network.Dr. Shah’s research, which has spans basic research in animal models, clinical physiologic studies, human clinical trials, and population-based epidemiology studies, has highlighted the heterogeneity and systemic nature of the HFpEF syndrome, and has improved the understanding of the risk factors, pathogenesis, and pathophysiology of HFpEF. He has also pioneered the use of machine learning for novel classification of cardiovascular diseases. Dr. Shah has served as the international principal investigator, executive committee member, or steering committee member for 18 multicenter randomized clinical trials and studies in heart failure. His work on clinical trials has contributed to the development of the first proven treatment for transthyretin cardiac amyloidosis, a highly fatal disease. Current research in his laboratory is focused on the molecular pathogenesis of abnormal cardiac mechanics; artificial intelligence for the automated interpretation of echocardiograms; adipocyte-endothelium-cardiomyocyte interactions; and the development of novel therapeutics for heart failure and microvascular dysfunction. Dr. Shah has published >235 peer-reviewed scientific research publications in leading medical journals, a textbook on cardiovascular genetics, and handbooks on internal medicine and cardiovascular disease. He is an associate editor of JAMA Cardiology, he is on the editorial board of Circulation: Heart Failure, and he has served as guest editor for the Journal of Cardiovascular Translational Research. His work has been cited over 6,700 times (Scopus, August 2018). Dr. Shah has mentored > 50 individuals throughout his career, including undergraduates, medical students, post-doctoral fellows, cardiology fellows, and early-stage faculty. He has received multiple teaching awards, including the George Joost MD, Teach of the Year Award at the Feinberg School of Medicine and the American College of Cardiology W. Proctor Harvey, MD Teaching Award. As an internationally recognized leading authority on HFpEF, Dr. Shah routinely lectures at international cardiology meetings, continuing medical education meetings, and academic institutions (including honorary lectures at Johns Hopkins University and Tufts University)
A medical director at Baylor University Medical Center, Dallas, Texas, US. Features in 1 video on Wondr Medical....
A medical director at Baylor University Medical Center, Dallas, Texas, US. Features in 1 video on Wondr Medical. Susan Joseph generally speaks on Heart Failure, Chronic Heart Failure, and Innovation.
William Altman, CEO, provides executive management oversight drawing on 25 years' of experience building healthcare...
William Altman, CEO, provides executive management oversight drawing on 25 years' of experience building healthcare companies. Mr. Altman is a former McKinsey & Co. consultant, and co-founded two firms that grew to over $50M revenues, including one healthcare services company that grew to 500 employees. He has served on the boards of five growth companies, including a 7,000 employee NASDAQ listed company which increased its market capitalization from $0.5 billion to $1.5 billion during his tenure, when it was successfully sold for cash. A native of New Ulm, Texas (pop. 500), Mr. Altman earned a B.S. degree in Electrical Engineering from Texas A&M University, an M.A. in Politics and Economics from Oxford University as a Rhodes Scholar, and an M.B.A. from Harvard Business School
A ceo at Append Medical, Or Yehuda, Israel. Features in 1 video on Wondr Medical. Zachi Berger generally speaks on...
A ceo at Append Medical, Or Yehuda, Israel. Features in 1 video on Wondr Medical. Zachi Berger generally speaks on Heart Failure, Chronic Heart Failure, and Innovation.
Start a conversation